metabolic
CagriSema
Amylin + GLP-1 combination research stack
0 vendors tracked0 live pricesLast crawl: 2026-04-27 01:38 UTC
About
A combination of cagrilintide and semaglutide in late-stage clinical development for obesity. Research-compound version mirrors the clinical dose ratio.
Also known as: Cagrilintide + Semaglutide combination
Related peptides